Delivery Order SPE2DB22D6029-SPE2DB24FLTGV
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of ABILIFY MAINTENA ER 400 MG VLS, a pharmaceutical product. The contract has a ceiling value of $1,843.01 and is a firm fixed price delivery order with a completion date of June 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $2,020.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. There is no set-aside...
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLUJE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.01 firm fixed-price delivery order is for the pharmaceutical product ABILIFY MAINTENA ER 400 MG VLS. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $10,608.25 firm-fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS medication. The delivery order has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,919.51 firm-fixed-price contract is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a prescription medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
This federal contract award is for the delivery of Abilify Maintena ER 400 mg vials to the Defense Logistics Agency (DLA). The $8,728.64 contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent organization Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $23,420.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of ABILIFY MAINTENA ER 400 MG SYRS, a medication for mental health treatment, with an ultimate completion date of December 23, 2024. Amerisourcebergen Drug...
This federal contract award, valued at $1,842.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Abilify Maintena ER 400 mg syringes, a medication used to treat certain mental health conditions. The contract is not a set-aside and represents an open competition. It has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,290.99 firm fixed-price delivery order is for ABILIFY MAINTENA ER 400 MG VLS, a specialty medication. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,647.00, for the delivery of ABILIFY MAINTENA ER 300 MG VLS pharmaceutical products. The contract has a period of performance extending through June 23, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery...